Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

NCT01744223

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

NCT02477878

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, not recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function

NCT03556280

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +26 more
Locations
  • Brain Matters Research Delray Beach, Florida, United States
  • Brain Matters Research Stuart, Florida, United States
  • ActivMed Practices & Research, Inc Methuen, Massachusetts, United States
  • Boston Center for Memory Newton, Massachusetts, United States
View Trial Details
Active, not recruiting

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

NCT03606577

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHU de Nantes Nantes, Pays de la Loire Region, France
  • CHU Caen Caen, France
  • CHRU Dijon Dijon, France
  • CHRU - Hôpital A.Michallon Grenoble, France
View Trial Details
Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details

Related conditions